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ARTICLE
Phosphorylation of CENP-A on serine 7 does not
control centromere function
Viviana Barra1,6, Glennis A. Logsdon2,3,7, Andrea Scelfo1, Sebastian Hoffmann1, Solène Hervé1, Aaron Aslanian4,
Yael Nechemia-Arbely5,8, Don W. Cleveland 5, Ben E. Black2,3 & Daniele Fachinetti 1
CENP-A is the histone H3 variant necessary to specify the location of all eukaryotic cen-
tromeres via its CENP-A targeting domain and either one of its terminal regions. In humans,
several post-translational modifications occur on CENP-A, but their role in centromere
function remains controversial. One of these modifications of CENP-A, phosphorylation on
serine 7, has been proposed to control centromere assembly and function. Here, using gene
targeting at both endogenous CENP-A alleles and gene replacement in human cells, we
demonstrate that a CENP-A variant that cannot be phosphorylated at serine 7 maintains
correct CENP-C recruitment, faithful chromosome segregation and long-term cell viability.
Thus, we conclude that phosphorylation of CENP-A on serine 7 is dispensable to maintain
correct centromere dynamics and function.
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The accurate segregation of chromosomes during cell divi-sion is crucial to preserve the integrity of genetic infor-mation. The centromere is a key element in this process: it
is the chromosomal locus that mediates the connection of the
chromosomes to the mitotic spindle microtubule fibers via the
formation of the kinetochore. Despite the recurrence of high
order repetitive sequences at centromeric regions, in most
organisms, centromeres are epigenetically specified by the H3
histone variant CENP-A (CENtromeric Protein A)1. CENP-A is
required to maintain centromere position and assembly via a two-
step mechanism2. First, CENP-A deposition occurs at the
beginning of G1 phase via tight regulatory mechanisms3. Second,
during interphase, it is required for the assembly of a network of
centromere components named the constitutive centromere
associated network (CCAN)4. The CCAN is then necessary to
mediate assembly of the kinetochore prior to mitosis when one
component, CENP-C, plays a central role5.
Similar to other H3 variants, CENP-A is composed of a
histone-fold domain that contains regions necessary for its
centromere targeting (the CENP-A centromere targeting
domain; CATD6), an extended amino-terminal tail, and a short
(6-aa) carboxy-terminal tail. Both the carboxy- and amino-
terminal tails of CENP-A and the CATD are required for the
assembly of key components of the CCAN2,7–9. The carboxy-
terminal tail of CENP-A directly interacts with CENP-C7,8,10
and is crucial for its correct maintenance at centromeres2,9. The
amino-terminal tail of CENP-A also takes part in CENP-C
mobilization but indirectly via its interaction with the DNA
binding protein CENP-B2,11 and its recruitment of CENP-T9.
Loss of either one of CENP-A's tails does not completely pre-
vent CENP-C binding to centromeres and cell viability2.
Altogether, this evidence suggests that both tails of CENP-A
function redundantly to ensure CENP-C recruitment to the
centromere and subsequent kinetochore assembly.
Post-translational modifications (PTMs) of centromeric
components have recently emerged as an important factor to
control centromere assembly and regulation. Specifically, CENP-
A undergoes PTMs that are proposed to control its chromosomal
location, its structure and stability within the nucleosome and its
function12. The function of several of these modifications,
however, remains controversial12–15. Great interest has been
placed on the PTMs of the CENP-A amino-terminus, since this
tail is highly divergent from the ones of all other H3 variants16. It
is enriched in arginines that do not appear to be frequently
modified and lacks most of the well-characterized lysines of
histone H3, known to be hotspots of conserved PTMs that reg-
ulate histone function17. PTMs on CENP-A’s amino-terminal
tail such as the α-N of glycine 1 and phosphorylation of Serine 7,
17, and 19 (hereafter named S718,19, S16 and S18 due to first
methionine digestion18,19) have also been detected, all of them to
some extent proposed to be important for CENP-A’s function-
ality19–24.
In particular, the phosphorylation (ph) of CENP-A S7 has
drawn much interest due to its similarities to the well-known
H3 S10ph, a hallmark of mitotic entry. CENP-A S7 is phos-
phorylated in prophase (after H3 S10ph), reaches its highest
level in prometaphase, and then starts to decrease during
anaphase18. CENP-A S7ph is performed initially by Aurora A
and maintained by Aurora B and C through telophase20,21,25.
The exact function of CENP-A S7ph is still under debate and
results are contradictory. An initial observation from Sullivan
and colleagues20 proposed a role for S7ph in the completion
of cytokinesis and Aurora B localization, supported by its
localization at the midbody in telophase that resembles
that of the chromosomal passenger proteins (Aurora B,
Survivin, Borealin, INCENP)26. Transient overexpression of a
non-phosphorylatable S7 (serine mutated to alanine, S7A)
CENP-A variant or of a variant that mimics phosphorylation at
S7 (serine mutated to glutamine, S7E) did not affect chromo-
some alignment, congression or separation20. In contrast,
Kunitoku et al.21 found that expression of CENP-A S7A results
in prometaphase delay and chromosome misalignment. Using
mutational analysis, the Dimitrov team further proposed
CENP-A S7ph to be essential for chromosome segregation by
directly controlling CENP-C binding to centromeres22. Indeed,
quite surprisingly, they found that ectopic expression of a
CENP-A S7A variant led to CENP-C loss and, consequently, to
mitotic errors and cell lethality. Recently, it was found that
preventing CENP-A S7ph led to sister chromatid cohesion
defects but no evidence of defective kinetochore assembly was
reported24.
Despite all these proposed functions for CENP-A S7ph, the
essential nature of such modification to maintain long-term
mitotic function of human centromeres was never tested. Addi-
tionally, in all these reports it was unclear if the observed effects
were caused by CENP-A being expressed at different levels
compared to its endogenous counterpart. Furthermore, results of
these experiments might be skewed due to the partial down-
regulation of endogenous CENP-A achieved by siRNA. Indeed,
CENP-A is a very stable and long-lived protein27, and therefore
difficult to reduce by RNAi technology2, and its levels are critical
for maintaining centromere identity and function28–31.
Taking advantage of recently developed powerful genome
editing technologies, here we describe three different approa-
ches to test the importance of CENP-A S7ph for centromere
function. First, we conditionally, rapidly, and completely
remove endogenous CENP-A using an auxin-inducible degron
(AID)32 tag following ectopic expression of CENP-A variants
from a unique genomic site to assess the importance of S7ph
during the first few cell cycles. Second, starting from cells with
one AID-tagged CENP-A allele, we use CRISPR/Cas9 to con-
vert the other endogenous allele of CENP-A to encode a S7
non-phosphorylatable version. After induced degradation of
the AID-tagged CENP-A13, we follow centromere function in
the subsequent cell cycles. Lastly, we perform endogenous
CENP-A gene inactivation to deplete endogenous CENP-A in
the presence of expression of a non-phosphorylatable S7
CENP-A variant2. In each approach, we score for CENP-A and
CENP-C localization, chromosome segregation and short- or
long-term viability. Altogether, our results demonstrate that
CENP-A S7ph does not play an essential role in any aspect of
known centromere function.
Results
Short-term centromere function does not require CENP-A
S7ph. We first tested if S7ph is required for maintenance of
centromere function in the short-term (in the 2nd to 14th cell
cycles) by using an inducible degradation system to rapidly
remove endogenous CENP-A from all centromeric regions. To do
this, we used a human pseudo-diploid cancer cell line DLD-1
expressing the plant F-box protein osTIR1-9xMyc33 that we had
engineered to carry one disrupted CENP-A allele, and the other
allele tagged with EYFP and AID (CENP-AEA)32. In this back-
ground, we introduced mRFP or EYFP versions of either wild-
type (WT) or mutant (S7A and S7E) CENP-A proteins, con-
stitutively expressed from a specific genomic locus (FRT site)34
(Fig. 1a, b). The AID system ensures rapid and complete degra-
dation of the endogenous CENP-A, following auxin hormone
indole-3-acetic acid (IAA) addition32, leaving only the
ectopically-expressed versions of CENP-A at centromeres
(Fig. 1c).
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Fig. 1 CENP-A S7ph is not required for short-term centromere function. a Schematics of the experiments. b Schematics representing the different CENP-A
constructs amino-terminally tagged with EYFP or mRFP. c Representative immunofluorescence images showing the working principles of the system.
Following IAA treatment for 24 h the EYFP signal of endogenous CENP-A disappears in both cell lines, while the mRFP signal of the exogenous CENP-A
remains at the centromere (marked by CENP-B spots) in the CENP-AmRFP cell line. Scale bar= 5 µm. d Representative immunofluorescence images
showing the localization of exogenous CENP-A constructs in the indicated cell lines. CENP-C staining is also shown revealing its localization in presence of
exogenous CENP-A constructs (IAA treatment for 24 h). Scale bar= 5 µm. e Quantification of CENP-C levels of the experiments in d. Error bars represent
the SEM of three independent experiments. Unpaired t-test: ****p < 0.0001. f Quantification of mitotic errors in the indicated cell lines calculated by live-
cell imaging observation after 2 days of IAA treatment. Error bars represent the SEM of four independent experiments. Unpaired t-test: ***p= 0.0008,
*p= 0.012 and 0.017. g Representative images of crystal violet-stained colonies from the colony formation assay. Cells were grown for 14 days to test their
clonogenic survival in presence or absence of endogenous CENP-A (controlled by IAA treatment). N= 3. Source data for graphs shown in e and f are
provided as a Source Data file
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Immunoblot for CENP-A confirmed that in all the tested cell
lines upon treatment with IAA the AID-tagged CENP-A was
degraded, while the ectopically encoded variants were still present
(Supplementary Fig. 1a). CENP-A variants that cannot be
phosphorylated on S7 (S7A) or that mimic S7ph (S7E) were
tested for the capability to support centromere assembly and
function by measuring the centromeric level of CENP-C, levels of
chromosome segregation defects, and overall cell viability. In the
absence of the endogenous CENP-A following its auxin-induced
degradation, CENP-A S7A and S7E correctly localized at
centromeres similarly to CENP-A WT (Fig. 1d). In addition,
preventing S7ph (S7A) did not affect CENP-C localization or its
levels at centromeres following auxin-mediated degradation of
CENP-A WT (Fig. 1d, e and Supplementary Fig. 1b). In contrast,
mimicking the constitutive phosphorylation (S7E) only partially
maintained CENP-C levels at centromeres (Fig. 1d, e), likely due
to the low accumulation of this variant (Supplementary Fig. 1a,
c). After replacing CENP-A WT with S7A, we could not detect
any significant increase in mitotic errors (misaligned and lagging
chromosomes observed) and micronuclei formation in the
absence of endogenous CENP-A when rescued with either WT
or S7A or S7E CENP-A variants, (compared to control cells) by
live-cell imaging (Fig. 1f). Mitotic duration was also not impaired
in S7A, and only slightly in S7E likely due to a reduced level of
CENP-A/CENP-C (Supplementary Fig. 1d).
Finally, short to medium term viability was assessed by colony
formation for 14 days and cell proliferation assay after continuing
degradation of endogenous CENP-A (IAA treatment). CENP-A
S7A mutant formed a comparable number of rescued colonies as
did cells with CENP-A WT (Fig. 1g and Supplementary Fig. 1e).
CENP-A S7E also supports cell viability but, in agreement with
the data above, with significantly reduced percentage of colony
formation. Analysis of cell proliferation also did not reveal any
growth defect of CENP-A mutants (Supplementary Fig. 1f). In
contrast, loss of CENP-A without any version of CENP-A rescue
allele caused a significant decrease in CENP-C level, increase in
mitotic errors and cell lethality, and suppression of colony
survival and cell proliferation (Fig. 1d–g and Supplementary
Fig. 1f), as previously described32. Finally, we also did not observe
any increase in the midbody length measured with acetylated
tubulin in CENP-A S7 mutants (Supplementary Fig. 1g),
suggesting no major defects in completing cytokinesis, in contrast
to an early report20.
These results demonstrate that preventing or mimicking
constitutive phosphorylation of S7 CENP-A is sufficient to rescue
the total absence of endogenous CENP-A. No significant increase
in mitotic errors—in terms of lagging, misaligned chromosomes
and micronuclei formation—or altered CENP-C localization has
indeed been detected. All these findings are inconsistent with an
essential role for S7ph in overall centromere function.
Recognizing that cells that have a more unstable karyotype
might be more sensitive to centromere manipulation, we next
tested the influence of CENP-A S7ph in a non-diploid cell line
such as HeLa, a line used in previous reports to assess the
importance of such PTM22,24. We tagged all endogenous HeLa
CENP-A alleles with an AID tag to permit its rapid, inducible
degradation (Supplementary Fig. 2a, b). CENP-A WT-EYFP or
S7A-EYFP constructs were then integrated by retroviral trans-
duction and the endogenous CENP-A depleted by IAA addition.
Similar to the results observed in DLD-1 cells, preventing CENP-
A S7ph did not affect CENP-C binding to centromeres
(Supplementary Fig. 2c) or short-term viability (Supplementary
Fig. 2d–f).
We previously showed that either the amino or the carboxy
tail of CENP-A is required to maintain CENP-C at centromeric
regions2,11,32. To further investigate the possible importance of
S7ph, we expressed a CENP-A/H3 chimera that contains the
centromere targeting domain (CATD) and amino-terminal tail
of CENP-A (NH2H3CATD), but lacks the CENP-A carboxy-
terminal tail, known to be the site for the direct interaction of
CENP-A with CENP-C7,8,10. This CENP-A/H3 variant has
reduced levels of CENP-C and an increased rate of chromosome
missegregation, although it is still capable of maintaining long-
term centromere function via its amino-terminal tail2. We
reasoned that if S7ph plays an important role in CENP-C
recruitment, this importance should be enhanced in cells lacking
the CENP-A carboxy-terminal tail. We integrated different
variants of NH2H3CATD in DLD-1 CENP-AEA/- cells using gene
integration at the FRT site, as done above (Fig. 1a and
Supplementary Fig. 3a, b). Following IAA addition, cells
expressing the NH2-S7AH3CATD variant that cannot be phos-
phorylated on S7 showed similar levels of centromeric CENP-C
as did those containing the correct S7 phosphorylation site
(NH2H3CATD) (Supplementary Fig. 3c, d). In addition, cells
during 14 days without endogenous CENP-A but rescued by
expression of NH2-S7AH3CATD formed a comparable number of
colonies to NH2H3CATD-expressing cells (Supplementary Fig. 3e).
In contrast, CENP-A variants in which all serines known (or
previously predicted) to be phosphorylated within the globular
part of CENP-A N-terminal tail (S7, S16, S18 and S26)
were mutated to alanines or aspartic acids (NH2-S--AH3CATD
and NH2-S--DH3CATD) only partially rescued endogenous CENP-
A depletion (Supplementary Fig. 3e–g). These latter results are
similar to the partial rescue of full CENP-A depletion with a
H3CATD or with a ΔNH2CENP-A variant lacking the N-terminal
tail2,11. Altogether, our results indicate that S7ph is not per se the
cause of impairment of CENP-A N-terminus functionality and is
not required to maintain the centromeric pool of CENP-C.
Rather, S16 and S18 are important for CENP-A N-terminus
functionality in line with the findings on the importance of S16
and S18 for centromere function19,35.
Endogenous CENP-A S7A does not affect centromere function.
Expression of CENP-A is known to be cell cycle regulated36.
Thus, we next tested whether preventing CENP-A S7ph by
directly modifying its endogenous locus (in order to preserve its
natural promoter) has an effect on maintenance of centromere
position and function. To this end, we used CRISPR/Cas9 tech-
nology in DLD-1 cells stably expressing the F-box protein TIR1-
9xMyc to replace the two endogenous CENP-A alleles with 1) an
inducible degradable CENP-A (EYFP-AID-CENP-A, hereafter
referred to as CENP-AEA) and 2) a SNAP-3xHA tagged version
of either a WT CENP-A allele or a S7A CENP-A variant (Fig. 2a
and Supplementary Fig. 4a). Following degradation of CENP-AEA
via the addition of IAA, CENP-A WT- or S7A -SNAP-3xHA
remained the only source of CENP-A (Supplementary Fig. 4b).
Immunoblot analysis showed that the CENP-A S7A-SNAP-3xHA
accumulated CENP-A to levels comparable to that of the AID-
tagged protein or WT-CENP-A-SNAP-3xHA (Supplementary
Fig. 4b). Further, immunofluorescence analysis revealed that
CENP-A S7A expression from an endogenous locus did not
impair CENP-A or CENP-C localization or their centromeric
accumulation (Fig. 2b, c and Supplementary Fig. 4c), nor did it
cause an increase in mitotic duration or in the rate of chromo-
some segregation errors (Fig. 2d, e).
Accordingly, CENP-A S7A-SNAP-3xHA fully rescued CENP-
AEA depletion after 8 or 14 days of IAA treatment as observed by
cell proliferation assay or colony formation, respectively, similarly
to CENP-A WT (Fig. 2f and Supplementary Fig. 4d, e).
Altogether, these results further demonstrate that preventing
CENP-A S7ph does not interfere with centromere function even
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when its expression is cell cycle regulated as for endogenous
CENP-A.
Long-term centromere function does not require CENP-A
S7ph. Finally, we tested if S7ph is required for long-term ( > 100
generations) maintenance of centromere identity and function.
To test this, we used RPE-1 cells engineered to have one CENP-A
allele inactivated by gene disruption and one floxed allele (CENP-
A−/F) that can be fully inactivated by the action of Cre recom-
binase2. CENP-A rescue constructs expressing EYFP fused to the
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Fig. 2 Endogenous CENP-A un-ph S7 does not affect centromere function. a Schematics representing the strategy used for the generation of the DLD-1 cell
line. b Representative immunofluorescence images showing the localization of CENP-A and CENP-C in the indicated cell lines (IAA treatment for 24 h).
Scale bar= 5 µm. c Quantification of CENP-C levels of the experiments in b. Error bars represent the SEM of three independent experiments. Unpaired
t-test: ****p < 0.0001. d Quantification of mitotic errors in the indicated cell lines calculated by live-cell imaging observation after 2 days of IAA treatment.
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amino-terminus of CENP-A WT or S7A were stably expressed by
retroviral integration. Additionally, we integrated rescue con-
structs of H3/CENP-A chimera NH2H3CATD with WT S7 or the
S7A variant to further test the importance of S7ph for CENP-C
maintenance at centromeres. Following inactivation of the floxed
CENP-A allele by Cre expression, we isolated surviving clones and
tested them for long-term centromere function and viability
(Fig. 3a). Immunoblot analysis confirmed the lack of endogenous
CENP-A in the isolated clones (Fig. 3b). Immunofluorescence
microscopy using a commercial antibody targeting CENP-A S7ph
confirmed the absence of detectable CENP-A S7 phosphorylation
(Fig. 3c). Furthermore, despite all cells have the unpho-
sphorylatable S7 CENP-A (or NH2H3CATD), CENP-C localization
and its levels at centromeres were unaffected relative to cells
rescued with CENP-A WT (Fig. 3d, e). Similarly, the intensities of
other centromeric components including CENP-B, CENP-T and
CENP-I and kinetochore proteins (Dsn1 and Hec1) were not
affected (Supplementary Fig. 5a, b).
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Long-term cell viability tested by colony growth assay
revealed that cells expressing a CENP-A S7A mutant formed
a similar number of colonies as the ones expressing a CENP-A
WT rescue construct (Fig. 3f and Supplementary Fig. 5c). We
also observed no differences in the duration of mitotic timing
and in the rates of micronuclei formation that would indicate
partial loss of centromere function, including defects in
centromeric cohesion (Fig. 3g and Supplementary Fig. 5d).
Accordingly, cells rescued with the unphosphorylatable S7
CENP-A variant continue to maintain a diploid state (Supple-
mentary Fig. 5e). In addition, Aurora B and INCENP
localization was unaffected in all stages of mitosis in CENP-A
depleted cells rescued long-term with a CENP-A S7A variant
(Supplementary Fig. 6a, b). Similarly, in DLD-1 cells Aurora B
localization at the inner centromere was not affected in
prometaphase-arrested cells following rapid endogenous
CENP-A depletion in cells expressing either S7A or S7E
(Supplementary Fig. 6c). Furthermore, we tested whether the
function of Aurora B in correcting kinetochore/microtubule
attachment was affected by treating cells with monastrol, a
chemical inhibitor of Eg5 required for outward force genera-
tion37. Following monastrol wash-out, we observed that the
error correction mechanism mediated by Aurora B was not
impaired in RPE-1 cells rescued with a CENP-A S7A variant,
while it was when cells were treated with the Aurora B inhibitor
ZM44743938 (Supplementary Fig. 6d). Only expression of the
NH2H3CATD variant, which lacks the C-terminal tail of CENP-
A, produced a slight but significant decrease in Aurora B
function independently of S7ph (Supplementary Fig. 6d).
Altogether, our results show that the non-phosphorylation of
CENP-A S7 does not affect centromere assembly
(including CENP-C localization) and function, chromosome
segregation fidelity, and overall cell viability even in the long-
term.
Discussion
Overall, our experimental evidence demonstrates that pre-
venting S7ph at CENP-A does not interfere with maintenance
of centromere position, assembly, or kinetochore formation via
CENP-C. Nor does this particular PTM negatively affects
chromosome segregation and short- (~2–14 divisions) or long-
term ( >100 divisions) cell viability. Our evidence includes
efforts modifying CENP-A endogenous loci (Fig. 2) or ectopi-
cally expressing a non-phosphorylatable variant in the complete
absence of endogenous CENP-A (Figs. 1 and 3).
Our results (Supplementary Fig. 1) also highlight how the level
of CENP-A is critical for centromere function (as in the case of
the CENP-A S7E variant): too little or too much can have dele-
terious effects on cell viability, in agreement with previous
results2,29,30,39. This might explain previously contradictory
reports on the importance of CENP-A S7ph that were obtained
with technologies that produced only partial CENP-A down-
regulation (achieved by RNAi) and/or transient rescue (known to
lead to a range of expression levels including overexpression40)
with CENP-A mutants20–22,24, as observed for other PTMs of
CENP-A13–15.
What role, if any, CENP-A S7ph may provide remains an open
question; however, our data strongly indicate that this post-
translational modification is not essential nor required for cen-
tromere function, in contrast to previous proposals20–22,24. While
our data do not exclude a function for S7 CENP-A phosphor-
ylation in some cell events such as maintenance of proper
cohesion via Shugoshin24, it argues that such function cannot be
essential for long-term cell cycling and chromosome segregation.
Moreover, CENP-A S7ph has never been found in mass
spectrometry data designed to identify CENP-A PTMs across the
cell cycle, including during mitosis19, suggesting that this PTM
might be at low abundancy, as recently suggested24. We also
could not detect CENP-A S7ph by mass spectrometry in any
phase of the cell cycle, including mitosis, further confirming that
this PTM might be present at very low levels, only occurring in a
small set of nucleosomes/cells, or extremely labile during pur-
ification steps and not detectable using classical trypsin peptide
digestion (Supplementary Fig. 7a–e). In contrast, our results with
CENP-A/H3 chimeras (NH2H3CATD), however, have confirmed
the importance of the CENP-A amino-terminal tail and its PTMs
on S16/18 for centromere biology, as previously demon-
strated2,9,19,23,35. Further studies are now necessary to address the
molecular mechanisms of how CENP-A N-terminal tail phos-
phorylations control centromere function.
Methods
Cell culture conditions. Cells were maintained at 37 °C in a 5% CO2 atmosphere.
DLD-1 (from S. Taylor) cells and HeLa (from H. Masumoto) cells were maintained
in Dulbecco's modified essential medium (DMEM) medium containing 10% fetal
bovine serum, 100 Uml−1 penicillin, and 100 μg ml−1 streptomycin. hTERT RPE-1
(from ATTC) cells were maintained in DMEM:F12 medium containing 10% fetal
bovine serum (Clontech), 0.348% sodium bicarbonate, 100 Uml−1 penicillin,
100 Uml−1 streptomycin and 2 mM L-glutamine. IAA (I5148; Sigma) was used at
500 μM, Monastrol (Selleckchem, S8439) was used at 100 µM for 10 h, ZM447439
at 2 μM for 3 h, and MG132 20 µM (Calbiochem) for 3 h. All cell lines were tested
for mycoplasma contamination.
Constructs. cDNAs used in the generation of HeLaEA/- TIR1 stable cell lines or
hTERT RPE-1 CENP-A-/F were cloned into a pBabe-based vector for retrovirus
generation. cDNAs used for the generation of DLD-1EA/- FRT TIR1 cell lines were
cloned into a pcDNA5/FRT expression vector. All CENP-A and H3 mutations
were generated via the Gibson assembly technique.
The plasmids used to generate the DLD-1 TIR1 cell lines via CRISPR/Cas9
[EGFP-AID-CENP-A, CENP-A(WT)-SNAP-3xHA-P2A-NeoR, and both
sgRNA/Cas9 plasmids (targeting the 5′ and 3′ ends of the endogenous CENP-A
gene)] were already constructed for Fachinetti and colleagues33. Briefly, the 5′
UTR and 3′UTR CENP-A gene regions (~800 bp each) were PCR-amplified
from DLD-1 TIR1 genomic DNA. EGFP was PCR-amplified from a derivative of
pBabePuro-LAP-CENP-N4, and AID was PCR-amplified from pcDNA5-FRT-
TO-H2B-AID-YFP33. The intronless CENP-A gene was designed using IDT’s
codon optimization tool, which chooses codons with a bias similar to the natural
bias in the human genome, and then synthesized as a gBlock gene fragment
(IDT). SNAP-3xHA-P2A-NeoR was also synthesized as a gBlock gene fragment.
pUC19 was digested with EcoRI and HindIII and purified, and then, the 5′UTR,
EGFP, AID, intronless CENP-A, 3′UTR, and pUC19 fragments were assembled
with NEBuilder HIFI DNA Assembly Master Mix (NEB E2621). Similarly, the 5′
UTR, codon-optimized CENP-A, SNAP-3xHA-P2A-NeoR, 3′UTR, and pUC19
fragments were also assembled using NEBuilder HIFI DNA Assembly Master
Mix. To generate the CENP-A(S7A)-SNAP-3xHA-P2A-NeoR repair template,
QuikChange site-directed mutagenesis (Agilent) was performed on CENP-A
(WT)-SNAP-3xHA-P2A-NeoR to convert S7 to an A. The sgRNA/Cas9
plasmids targeting the 5′UTR and 3′UTR of the CENP-A gene were constructed
by annealing oligos and then ligating them into pX33041 at the BbsI cut sites. For
the 5′ UTR CENP-A sgRNA, the following oligos were annealed: 5′-
CACCGgtgtcatgggcccgcgccgc-3′ and 5′-AAACgcggcgcgggcccatgacacC-3′. For
the 3′ UTR CENP-A sgRNA, the following oligos were annealed: 5′-
CACCGctgacagaaacactgggtgc-3′ and 5′-AAACgcacccagtgtttctgtcagC-3′. All
plasmids were verified by sequencing using commercial primers.
Generation of stable cell lines. Stable DLD-1EA/- FRT TIR1 cell lines expressing
the different CENP-A variants were generated by using the FRT/FlpIN system.
Briefly, parental Flp-In TRex-DLD-1 were co-transfected with pcDNA5/FRT
plasmid expressing CENP-A variants and plasmid pOG44 expressing the Flp
recombinase using electroporation. Following selection in 400 µg ml−1 hygro-
mycin (Invitrogen), colonies were pulled together and grown for 1 week. The
expression of the constructs was checked by immunoblotting. For HeLa or RPE-
1 cells the CENP-A constructs were introduced by retroviral delivery. Stable
integrates were selected in 5 µg ml−1 puromycin or 10 µg ml−1 blasticidin S and
single clones were isolated and checked for construct expression by immuno-
blotting and immunofluorescence microscopy. Clones with similar expression
levels were then pooled together. To generate DLD-1 TIR1 stable cell lines in
which both alleles of CENP-A were replaced via CRISPR/Cas9 gene-editing, 400
ng of each repair template [EGFP-AID-CENP-A plasmid and CENP-A(WT or
S7A)-SNAP-3xHA-P2A-NeoR plasmid] and 100 ng of each sgRNA/Cas9 plas-
mid (5′UTR sgRNA/Cas9 plasmid and 3′UTR sgRNA/Cas9 plasmid)13 were co-
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transfected into DLD-1 TIR1 cells33 using Lipofectamine 2000 (Invitrogen).
Seven days after transfection, 750 μg ml−1 G418-S was added to the culture
medium, and cells were cultured with G418-S for 3–4 weeks. GFP-positive cells
were sorted by FACS into monoclonal lines in 96-well plates, and surviving
clones were assessed by immunofluorescence microscopy and immunoblotting.
Monoclonal cell lines of the indicated genotypes were verified, including
for the presence of the indicated mutation, by PCR and sequencing of genomic
DNA.
Clonogenic assay. In all experiments, 5000-1000-200 cells were plated on 6-well
plates and 500 μM IAA was added the day after seeding. After 14 days, colonies
were fixed 10 min in methanol and stained for 10 min using a crystal violet staining
solution (1% crystal violet, 20% EtOH). The experiment was repeated at least three
times for each cell line.
Cell proliferation assay. For WST-1 cell proliferation assay, 1 × 103 cells per well
were seeded in a 96-well plate in duplicate for each day of the growth curve. IAA-
treated cells were previously grown for 48 h in presence of IAA before plating. For
daily measurements, cells were grown for 3 h in presence of WST-1 reagent
(Sigma-Aldrich) added at 1:10 final dilution. The absorbance was measured at λ=
450 nm with a microplate reader (Fluostar) using λ= 690 nm as reference wave-
length. The experiment was performed in triplicate for each cell line.
Immunoblotting. For immunoblot analysis, whole-cell lysates were separated by
sodium dodecyl sulphate polyacrylamide gel electrophoresis, transferred onto
nitrocellulose membranes (Bio-Rad), and then probed with the following anti-
bodies: DM1A (α-tubulin, 1:5000, BD), CENP-A (1:1000, Cell Signalling #2186S
or Abcam #ab13939), ACA (2 μg ml−1, Antibodies-Online GmbH, 15-235-
0001), GAPDH (1:2000, Cell Signalling, 14C10). Not cropped immunoblots
are shown in Source Data file. The experiment was repeated twice for each
cell line.
Immunofluorescence and live-cell microscopy. Cells were pre-extracted with
PBS in 0.1% Triton-X for 1 min, fixed in 4% formaldehyde in PBS at room tem-
perature for 10 min, then washed in 0.1% Triton-X in PBS. Cells were blocked in
2% FBS, 2% BSA, and 0.1% Tween in PBS (blocking buffer) for at least 30 min.
Incubations with primary antibodies were conducted in blocking buffer for 1 h at
room temperature using the following antibodies: CENP-A (3–19) mouse mono-
clonal antibody (1:1000, ADI-KAM-CC006-E; Enzo), CENP-C (1:1000; Clin-
isciences, PD030), CENP-B (1:1000; Abcam, ab25734), Ph-CENP-A-ser7
(Covance, 1:100018), ACA (1:500; Antibodies-Online GmbH, 15-235-0001), Aur-
ora B (Abcam ab2254, 1:1000), INCENP (Covance, 1:100) and HA (A-M-M#07, I.
Curie platform), Acetylated tubulin (1:100; Sigma-Aldrich, T7451).
For chromosome spreads, cells were incubated with colcemid (100 ng ml−1) for
3 h and then subjected to a hypotonic buffer treatment (with 40% of water) for 5
min at room temperature (RT) on a glass coverslip. Subsequently, cells were
centrifuged for 3 min at 800 x g on a coverslip, fixed in 4% formaldehyde and then
subjected to immunofluorescence as done above.
Immunofluorescence images were collected using a Deltavision Core system
(Applied Precision). FITC-, Cy3-, and Cy5-conjugated secondary antibodies
(Jackson lab) were used at a 1:500 dilution and incubated for 50 min. Cells were
DAPI-stained and mounted with ProLong Antifade Mountant (Thermo Fisher
Scientific) onto glass slides prior to imaging. For the live-cell imaging, cells were
plated on high optical quality plastic slides (ibidi) treated 1 h before filming with
siRDNA (1:1000) (in cells that do not stably expressing H2BmRFP) and imaged
using a Deltavision Core system (Applied Precision) or an inverted spinning disk
confocal (Gattaca/Nikon).
Images quantification. All experiments in which we performed quantifications
were repeated independently at least three times. All replicates show a similar
experimental variation.
Interphase centromere quantifications: Quantification of centromere signal
intensity on interphase cells was done manually2 and using two automated
systems42. Briefly, for the manual quantifications a 15 × 15 pixel circle was drawn
around a centromere (marked by CENP-B staining) and a circle of the same size
drawn in the vicinity of the centromere (background). The integrated signal
intensity of each individual centromere was calculated by subtracting the
background from the intensity of the adjacent centromere. For the automated
quantification, a mask of the nuclei was obtained by thresholding the DAPI
channel and individual nuclei were detected using the Analyze Particles function.
For each nucleus, the XY positions of centromeres were detected using the Find
Maxima function on the centromere channel (CENP-B staining). Then, the mean
fluorescence intensity of the channel of interest was measured in a circle of 0.3 µm
radius around each centromere position. Background correction was performed by
subtracting the lowest pixel intensity value within the circle to the mean intensity
value of the circle. The centromeric values in a nucleus were averaged to provide
the average fluorescence intensity for each individual cell and more than 30 cells
were quantified per experiment.
Metaphase spreads centromere quantification: In order to measure the
fluorescence intensity of Aurora B at metaphase-arrested centromeres, points were
manually chosen outside the two centromeres of each individualized chromosome.
A line was then drawn between the two points and the fluorescence along the line
was measured for each channel using the Plot profile function in Fiji. Background
correction was performed by subtracting the lowest pixel intensity value to the
intensity values along the line. The line length was normalized in order to compare
and pool data coming from different chromosomes; the fluorescence intensity
values were extrapolated accordingly.
Midbody length measurement: The length of the acetylated tubulin bridges in
dividing cells was measured with the segmented line tool in Fiji. Beta-catenin was
used to discriminate cell contours.
Immunoprecipitation and mass spectrometry. TAP-tagged complexes were
purified from chromatin and soluble fraction as previously described4,43 by tandem
affinity purification using Rabbit IgG coupled to Ultralink resin, TEV cleavage and
S-protein agarose beads. Mass spectrometry was performed following peptides
trypsin digestion directly on beads. For that, samples were first denatured in 8 M
urea and then reduced and alkylated with 10 mM Tris(2-carboxyethyl) phosphine
hydrochloride [Roche Applied Science] and 55 mM iodoacetamide [Sigma-
Aldrich] respectively. Samples were then diluted using 100 mM Tris pH 8.5 to a
final concentration of 2 M urea and digested with trypsin [Promega] overnight at
37 ºC.
For the phosphopeptide enrichment experiment, digested peptides were further
captured by magnetic titanium dioxide beads [Pierce] according to the
manufacturer’s specifications. Briefly, acetonitrile was added to each sample at a
final concentration of 80% prior to the addition of the titanium dioxide magnetic
beads using a ratio of one microliter stock beads to ten micrograms digested
peptides. The magnetic beads were incubated four times in binding buffer and four
times in wash buffer prior to elution of the phosphopeptides. The eluate was
lyophilized and re-suspended in 5% acetonitrile/0.1% formic acid (buffer A).
Digested peptides were pressure-loaded onto split column placed in line with a
1200 quaternary high pressure liquid chromatography (HPLC) pump [Agilent
Technologies] and the eluted peptides were electrosprayed directly into an LTQ
Orbitrap Velos mass spectrometer [Thermo Scientific]. A 180 min elution gradient
was run twice. The MS/MS cycle consisted of one full scan mass spectrum
(400–1600 mz−1) at 60 K resolution followed by ten data-dependent collision
induced dissocation (CID) MS/MS spectra. Charge state exclusion was enabled
with+ 1 and unassigned charge states rejected for fragmentation. Application of
mass spectrometer scan functions and HPLC solvent gradients were controlled by
the Xcalibur data system [Thermo Scientific].
MS/MS spectra were extracted using RawXtract (version 1.9.9). MS/MS spectra
were searched with the ProLuCID algorithm44 against a human UniProt protein
database downloaded on 25-03-2014 that had been supplemented with common
contaminants and concatenated to a decoy database in which the sequence for each
entry in the original database was reversed. The ProLuCID search was performed
using full enzyme specificity (cleavage C-terminal to Arg or Lys residue), static
modification of cysteine due to carboxyamidomethylation (57.02146) and variable
modification of serine/threonine/tyrosine due to phosphorylation (79.9663). The
data were searched using a precursor mass tolerance of 50 ppm and a fragment ion
mass tolerance of 600 ppm. The ProLuCID search results were assembled and
filtered using the DTASelect (version 2.0) algorithm45. DTASelect assesses the
validity of peptide-spectra matches using the cross-correlation score (XCorr) and
normalized difference in cross-correlation scores (deltaCN). The search results are
grouped by charge state and tryptic status and each sub-group is analyzed by
discriminant analysis based on a non-parametric fit of the distribution of forward
and reversed matches. Only modified peptides were considered and a minimum of
one peptide was required for each protein identification. All peptide-spectra
matches had <10 ppm mass error. The peptide false-positive rate was below one
percent for all experiments. Phosphosite localization was performed using AScore.
AScore is a modification localization score. A value > 13 indicates 95% confidence
and a value of > 20 indicates 99% confidence46.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data supporting the findings of this study are available within the article and its
Supplementary Information files or from the corresponding author upon reason-
able request. The computer codes for image quantifications are available from the
corresponding author upon request. The source data underlying Figs. 1e, f, 2c–e,
3b, e, g and Supplementary Figs. 1a, 2a, 3b, 4a, and 7 are provided as a Source Data
file. The raw data of the mass spectrometry (MS) results are available from the
corresponding author upon request. The MS proteomics data of the the phosho-
peptide enrichment have been deposited to the ProteomeXchange Consortium via
the PRIDE partner repository under the dataset identifier PXD012163.
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